Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With ...
Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — Two surgeons have developed a new classification system called the UCS, or Universal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback